Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Immune Cell Function and Interaction, and Ferroptosis and cancer prognosis.
Metabolism drives macrophage heterogeneity in the tumor microenvironment
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance
Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L